Cargando…
Gut Microbiota Metabolites in NAFLD Pathogenesis and Therapeutic Implications
Gut microbiota dysregulation plays a key role in the pathogenesis of nonalcoholic fatty liver disease (NAFLD) through its metabolites. Therefore, the restoration of the gut microbiota and supplementation with commensal bacterial metabolites can be of therapeutic benefit against the disease. In this...
Autores principales: | Chen, Jiezhong, Vitetta, Luis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7432372/ https://www.ncbi.nlm.nih.gov/pubmed/32717871 http://dx.doi.org/10.3390/ijms21155214 |
Ejemplares similares
-
Modulation of Gut Microbiota for the Prevention and Treatment of COVID-19
por: Chen, Jiezhong, et al.
Publicado: (2021) -
Gut-brain axis in the neurological comorbidity of COVID-19
por: Chen, Jiezhong, et al.
Publicado: (2021) -
Commensal bacterial metabolites may strengthen the effect of anti-IL6 treatment for COVID-19
por: Chen, Jiezhong, et al.
Publicado: (2021) -
Gut Microbiota and NAFLD: Pathogenetic Mechanisms, Microbiota Signatures, and Therapeutic Interventions
por: Hrncir, Tomas, et al.
Publicado: (2021) -
Gut Dysbiosis Could Be a Major Factor for the Effects of Low-Grade Endotoxemia in COVID-19 Comment on: Low-Grade Endotoxemia and Thrombosis in COVID-19
por: Chen, Jiezhong, et al.
Publicado: (2022)